Acadia Healthcare is a leading provider of addiction treatment and behavioral healthcare services in the USA, the UK, and Puerto Rico. Worldwide, they operate a network of 593 facilities with 18,100 beds in 40 U.S. States. Of these locations, Acadia offer medication-assisted opioid treatment in 127 of their facilities.

In 2019, Acadia added 11 additional U.S. clinics to the Methadone.US national directory list …

1. Aberdeen, WA – Grays Harbor Treatment Solutions
2. Escondido, CA – Mission Treatment Services of Escondido
3. Henderson, NV – Mission Treatment Center of Henderson
4. Las Vegas, NV – Mission Treatment Center of Las Vegas
5. Mansfield, OH – Mansfield Comprehensive Treatment Center
6. Oceanside, CA – Mission Treatment Services of Oceanside
7. Oklahoma City, OK – Mission Treatment Center of Hefner
8. Oklahoma City, OK – Mission Treatment Center of Oklahoma City
9. San Diego, CA – Mission Treatment Services of Clairemont Mesa
10. Scottsdale, AZ – Mission Treatment Center of Scottsdale
11. Tulsa, OK – Mission Treatment Center of Oklahoma City

While Acadia are experts in the treatment of opioid misuse disorders, they treat a wide variety of addiction-related problems utilizing traditional outpatient programs up to inpatient detoxification and residential treatment. You can view Acadia’s Levels of Care descriptions to gain a better view of the breadth of their substance abuse services.

Here is a complete listing of Acadia opioid treatment clinics.

Recovery from opioid addiction initially centers around physical stabilization: specifically the management of opioid withdrawal. This is an essential step for the vast majority of opioid addicted people seeking help. Research has shown a 90% failure rate for opioid treatment programs that do not offer medication assistance.

Methadone was the original medication FDA-approved for treating opioid addiction although Subutex has been recently introduced into opioid treatment programs around the country as a viable alternative. Subutex is effective especially for milder levels of opioid dependency.

Subutex is a brand name version of buprenorphine, the partial opioid agonist that reduces withdrawal symptom sickness. Most patients are familiar with “Suboxone” which is a popular buprenorphine-based film that is dissolved under the tongue and is taken once per day. It differs from Subutex in that it contains naloxone so that it cannot be easily abused intravenously.

A number of methadone clinics began offering subutex in the past few years in an effort to expand treatment options for patients. Because subutex can be abused, it is typically administered daily in the clinic by a nurse where it can be supervised.

If you are considering entering a treatment program for opioid misuse, you may want to ask about the variety of medications utilized by the clinic or physician. Some patients have successfully transitioned from methadone to subutex while others enter the program starting with subutex. This is a decision best made in conjunction with your treating doctor who can formulate a treatment plan based on your history of opioid use.

Methadone programs and doctors who prescribe buprenorphine serve a very important function in helping the country cope with the opioid crisis. They are also a life-saving link for patients who have suffered for years with an overwhelming addiction.

Operating a methadone clinic or buprenorphine/suboxone practice is typically a complex endeavor. Clinics that offer medication-assisted treatment (MAT) must comply with a myriad of mandates and policy requirements from the DEA, the local State Methadone Authority, accreditation organizations like CARF and JCAH, SAMHSA (the Substance Abuse and Mental Health Services Administration}, and 3rd party payers who help fund treatment services.

Patients understand that a well-run treatment clinic offers many benefits. Quality services are only delivered when there is an organizational commitment to helping people while also being able to meet all of the operational requirements such as timely documentation of services (paperwork) and appropriate support of staff & counselors,

Sometimes patients will complain about “so many clinic rules” although many patients appreciate their clinic’s dedication to professionalism and its ability to meet the standards of good quality care. Within most treatment facilities are several key staff who oversee its daily operation and the provision of services. These are the Clinical Director, the Medical Director or primary prescribing physician, the Nurse Supervisor, and possibly clinical staff Team Leaders who do the work of coordinating the clinics many daily activities.

While the list of clinic rules can seem long, there is nearly always an important underlying reason for that rule to exist. Most methadone clinics distribute a Handbook for clients that outlines their rights as an opioid treatment patient as well as guidelines for obtaining dosage adjustments and progressing successfully through treatment.

Opioid treatment, and medication-assistance in particular, must be carefully monitored. This is to insure patient safety and to minimize the risk of medication errors. Please support your local methadone or suboxone clinic with words of encouragement and positive feedback when it is earned. Conversely, it is important to speak up as well if serious problems are occurring. Always make an effort to communicate first with the clinic’s clinical and administrative staff if experiencing a problem. If an honest effort to resolve an issue in this manner is not productive, then contacting one’s local State Methadone Authority is sometimes a logical next step for addressing an important concern.

Several organizations in Ohio recently hosted a town hall discussion on the opioid crisis still occurring there and across the country. News commentator, Eric Bolling, was a moderator of the event which was held at Cedarville University.

Eric and his wife, Adrienne, lost their 19 year old son in 2017 due to an accidental overdose with the powerful opioid, fentanyl.

This town hall discussion was designed to continue raising public awareness on the danger of opioid misuse and the continuing need for treatment and recovery support services to help families deal with this perpetual problem.

The Centers for Disease Control (CDC) report that there were 70,237 drug overdoses in 2017 with 47,600 involving opioids specifically. The article linked above states that the state of Ohio ranked 2nd in overdose deaths only behind West Virginia.

There is promising news in that more Americans are now being educated on opioid risks, and consequently are taking better precautions as well as actively accessing methadone & suboxone programs offering helpful medication-assistance and behavioral counseling. Saving lives and offering recovery are messages that are being heard.

In past decades, opioid addiction was skewed more heavily toward an older generation of adults. But today we have larger numbers of youth using opioids and experiencing addiction-related problems at earlier ages. Importantly, research has demonstrated conclusively that those who remain engaged in treatment for six months or more are much more likely to stabilize and to enjoy sustained success with recovery.

A recent Reuters Health article highlights the fact that many opioid-addicted youth are either not yet engaging in treatment or are exiting treatment too early. While more youth are being saved through the overdose reversal drug naloxone, a majority of addicted youth are still not receiving medicated-assisted treatments such as buprenorphine or methadone.

More work is necessary to open up treatment avenues for young adults across America, and to both educate & compel youth to seek MAT (medication-assisted treatment) as soon as possible.

The opioid addiction problem in America will not soon disappear. Drugs continue to find their way across the U.S. border through multiple avenues. Positive efforts are indeed bringing needed change, but the complexity and extent of opioid addiction in the U.S. will require a long-term, sustained commitment throughout the country. We must get the message out – especially to young people who may not fully grasp the power of addiction!